Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions
Loredana Raciti, Gianfranco Raciti, David Militi, et al.
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 5
Open Access | Times Cited: 12

Showing 12 citing articles:

Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine
Cinder Faith Cohen, Jueun Roh, Sang Hoon Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7897-7897
Open Access | Times Cited: 11
Botulinum Toxin Therapy: A Comprehensive Review on Clinical and Pharmacological Insights
Nahla Ayoub
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2021-2021
Open Access
A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role
Licia Grazzi, Danilo Antonio Montisano, Paul Rizzoli, et al.
Toxins (2023) Vol. 15, Iss. 2, pp. 86-86
Open Access | Times Cited: 9
The TRPA1 Ion Channel Mediates Oxidative Stress-Related Migraine Pathogenesis
Michał Fila, Łukasz Przysło, Marcin Derwich, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3385-3385
Open Access | Times Cited: 2
Xeomin®, a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury
Valentina Mastrorilli, Federica De Angelis, Valentina Vacca, et al.
Toxins (2023) Vol. 15, Iss. 4, pp. 248-248
Open Access | Times Cited: 6
Targeting Nociceptors and Transient Receptor Potential Channels for the Treatment of Migraine
Cinder Faith Cohen, Jueun Roh, Sang Hoon Lee, et al.
(2023)
Open Access | Times Cited: 5
Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study
David García‐Azorín, Blanca Martínez, María J. Gutiérrez, et al.
Toxins (2022) Vol. 14, Iss. 12, pp. 850-850
Open Access | Times Cited: 4
Botulinum toxin is a new drug for the treatment of migraine
M. I. Lastovetska, I. O. Mudryk, V. P. Maslii, et al.
Reports of Vinnytsia National Medical University (2024) Vol. 28, Iss. 4, pp. 755-759
Open Access
Continuous Unilateral Cephalalgia Due to Systemic Lupus Erythematosus: A Case Report
Lucas Teixeira, Matheus Roriz Cruz
Deleted Journal (2024) Vol. 15, Iss. 1, pp. 35-37
Open Access
Dilution of botulinum toxin type A in local anesthetics: a therapeutic opportunity in migraine treatment
Eduardo de Almeida Guimarães Nogueira, Élcio Juliato Piovesan, Mário Fernando Prieto Peres
Deleted Journal (2024) Vol. 15, Iss. 2, pp. 43-46
Closed Access
https://jptcp.com/index.php/jptcp/article/view/4925
Nasser Obaidallah Almuzaini, Amany Mohammad Mohammad Sahli, Roaa Ahmad Mohammed Shbaily, et al.
(2023)
Open Access
The Application of Botulinum Toxin in the Prophylactic Treatment of Migraine
Dominika Kuźmiuk, Paulina Pawłowska, Aleksandra Skorupa, et al.
Polish Hyperbaric Research (2023) Vol. 85, Iss. 4, pp. 63-72
Closed Access
Page 1

Scroll to top